The European Tribune is a forum for thoughtful dialogue of European and international issues. You are invited to post comments and your own articles.
Please REGISTER to post.
The deadly Ebola outbreak in eastern Congo has surpassed 2,000 cases and is picking up speed. ... The outbreak declared in August, the second-deadliest in history, has killed more than 1,300 people in a volatile region where rebel attacks and community resistance have hurt containment efforts. ... Each attack keeps health workers from the crucial work of vaccinating people and tracking thousands of contacts of victims. ... Misunderstandings have been high in a region that had never [?!] experienced an Ebola outbreak until now [...] Amid the challenges, WHO and others have pointed out signs of progress. Notably, more than 129,000 people have received an experimental but effective Ebola vaccine in its first widespread use.[11 June 2018, unidentified vaccine] She said the hospital never showed her records confirming he'd tested positive for the virus. [...] Congo's health ministry and the WHO rushed in 7,500 doses, created by the Public Health Agency of Canada and owned by Merck. [...] The vaccine must be kept at a temperature of minus 76 to minus 112 degrees Fahrenheit (minus 60 to minus 80 degrees Celsius), and can only be kept in mobile freezers for up to seven days. [...] Next year, Merck plans to seek approval of the vaccine from the U.S. Food and Drug Administration, based on previous studies [?] of the shots. While the vaccine is[ not] being formally studied in the current Congo outbreak, regulatory authorities would want to know if unforeseen side effects crop up. "If it's fully approved then in each outbreak it'll be the first measure and could be used all over the region," Dr. Jean-Jacques Muyembe, director general of the National Institute for Biomedical Research in Kinshasa told the AP. In ["]West Africa["], a large study is underway that compares the Merck shot and a second vaccine candidate [?] made by Janssen Pharmaceuticals to determine best vaccination strategies and track how long [?!] protection lasts.
[11 June 2018, unidentified vaccine] She said the hospital never showed her records confirming he'd tested positive for the virus. [...] Congo's health ministry and the WHO rushed in 7,500 doses, created by the Public Health Agency of Canada and owned by Merck. [...] The vaccine must be kept at a temperature of minus 76 to minus 112 degrees Fahrenheit (minus 60 to minus 80 degrees Celsius), and can only be kept in mobile freezers for up to seven days. [...] Next year, Merck plans to seek approval of the vaccine from the U.S. Food and Drug Administration, based on previous studies [?] of the shots. While the vaccine is[ not] being formally studied in the current Congo outbreak, regulatory authorities would want to know if unforeseen side effects crop up. "If it's fully approved then in each outbreak it'll be the first measure and could be used all over the region," Dr. Jean-Jacques Muyembe, director general of the National Institute for Biomedical Research in Kinshasa told the AP. In ["]West Africa["], a large study is underway that compares the Merck shot and a second vaccine candidate [?] made by Janssen Pharmaceuticals to determine best vaccination strategies and track how long [?!] protection lasts.
"If it's fully approved then in each outbreak it'll be the first measure and could be used all over the region," Dr. Jean-Jacques Muyembe, director general of the National Institute for Biomedical Research in Kinshasa told the AP.
In ["]West Africa["], a large study is underway that compares the Merck shot and a second vaccine candidate [?] made by Janssen Pharmaceuticals to determine best vaccination strategies and track how long [?!] protection lasts.
archived 4 May 2019 living lab 12 May 2018 Ebola Vaccines Shipped to Congo, WHO Chief Says; AFRICOM Gen.Thomas Waldhauser, Haley, Kabila 2017 bargaining Diversity is the key to economic and political evolution.
by gmoke - Mar 3
by rifek - Feb 24 4 comments
by Oui - Mar 1 4 comments
by Oui - Mar 1
by gmoke - Feb 25
by Oui - Mar 14 comments
by Oui - Feb 284 comments
by Oui - Feb 28
by Oui - Feb 2710 comments
by Oui - Feb 26
by Oui - Feb 262 comments
by Oui - Feb 25
by Oui - Feb 24
by rifek - Feb 244 comments
by Oui - Feb 23
by Oui - Feb 22
by Oui - Feb 222 comments
by Oui - Feb 21
by Oui - Feb 203 comments